The determination of oxidative damage in heart tissue of rats caused by ruthenium(II) and gold(I) N-heterocyclic carbene complexes

Toxicology and Industrial Health

Volumn 27, Issue 8, 2011, Pages 735-741

  Ciftci, Osman ^a   Ozdemir, Ilknur ^a   Cakir, Oguz ^a   Demir, Serpil ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

gold(I); heart tissue; NHC complexes; oxidative stress; Ruthenium(II)

Indexed keywords

CARBENE; CATALASE; GLUTATHIONE; GOLD COMPLEX; MALONALDEHYDE; RUTHENIUM COMPLEX; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; ENZYME ACTIVITY; HEART; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANALYSIS OF VARIANCE; ANIMALS; CATALASE; COORDINATION COMPLEXES; GLUTATHIONE; GOLD; HEART; HETEROCYCLIC COMPOUNDS; MALE; MALONDIALDEHYDE; METHANE; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RUTHENIUM; SUPEROXIDE DISMUTASE;

ANIMALIA; RATTUS;

EID: 80054774739     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233710395993     Document Type: Article

References (29)

1. Aebi H. (1984) Catalase in vitro assay methods. Methods in Enzymology, 105: 121-126.
2. Babu E., Gopalakrishnan VK, Sriganth IN, Gopalakrishnan R., and Sakthisekaran D. (1995) Cis-platin ınduced nephrotoxicity and the modulating effect of glutathione ester. Molecular and Cellular Biochemistry, 144: 7-11.
3. Ciftci O., Ozdemir I., Vardi N., and Gurbuz N. (2010) Novel platinum-N-heterocyclic carbene complex is more cardiotoxic than cis-platin in rats. Human Experimental Toxicology DOI: 10.1177/0960327110390064.
4. Clarke MJ (2003) Ruthenium metallopharmaceuticals. Coordination Chemistry Reviews, 236: 209-233.
5. Custódio JB, Cardoso CM, Santos MS, Almeida LM, Vicente JA, and Fernandes MA (2009) Cis-platin impairs rat liver mitochondrial functions by inducing changes on membrane ion permeability: prevention by thiol group protecting agents. Toxicology, 2;259:18-24.
6. Demir S., Özdemir İ., and Çetinkaya B. (2009) Synthesis and catalytic properties of novel ruthenium N-heterocyclic-carbene complexes. The Journal of Organometallic Chemistry, 694: 4025-4031.
7. Hara M., Yoshida M., Nishijima H., Yokosuka M., Iigo M., Ohtani-Kaneko R., et al. (2001) Melatonin, a pineal secretory product with antioxidant properties, protects against cisplatin-ınduced nephrotoxicity in rats. Journal of Pineal Research, 30: 129-138.
8. Hartinger CG and Dyson PJ (2009) Bioorganometallic chemistry-from teaching paradigms to medicinal applications. Chemical Society Reviews, 38: 391-401.
9. Kreuser ED, Keppler BK, Berdel WE, Piest A., and Thiel E. (1992) Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines. Seminars in Oncology, 19: 73-81.
10. Li H. and Qian ZM (2002) Transferrin/transferrin receptor-mediated drug delivery. Medical Research Reviews, 22: 225-250.
11. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ (1951) Protein measurement with pholin phenol reagent. Journal of Biological Chemistry, 193: 265-275.
12. Luo J., Tsuji T., Yasuda H., Sun Y., Fujigaki Y., and Hishida A. (2008) The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrology Dialysis Transplant, 23: 2198-2205.
13. Mansour MA, Mostafa AM, Nagi NM, Khattab MM, and Al-Shabanah OA (2002) Protective effect of aminoguanidine against nephrotoxicity ınduced by cisplatin in normal rats. Comparative Biochemistry and Physiology Part C, 132: 123-128.
14. Mazumder UK, Gupta M., Karki SS, Bhattacharya S., Rathinasamy S., and Sivakumar T. (2005) Synthesis and pharmacological activities of some mononuclear Ru(II) complexes. Bioorganic & Medicinal Chemistry, 13: 5766-5773.
15. McKeage MJ, Maharaj L., and Berners-Price SJ (2002) Mechanisms of cytotoxicity and antitumor activity of gold(I) phosphine complexes: the possible role of mitochondria. Coordination Chemistry Reviews, 232: 127-135.
16. Mirabelli CK, Hill DT, Faucette LF, McCabe FL, Girard GR, Bryan DB, et al. (1987) Antitumor activity of bis (diphenylphosphino) alkanes, their gold(I) coordination complexes, and related compounds. Journal of Medical Chemistry, 30: 2181-2190.
17. Mirabelli CK, Johnson RK, Hill DT, Faucette LF, Girard GR, Keu GY, et al. (1986) Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold(I) coordination complexes. Journal of Medical Chemistry, 29: 218-223.
18. Montjean D., Ménézo Y., Benkhalifa M., Cohen M., Belloc S., Cohen-Bacrie P., and De Mouzon J. (2010) Malonaldehyde formation and DNA fragmentation: two independent sperm decays linked to reactive oxygen species. Zygote, 18: 265-268.
19. Ozdemir İ., Temelli N., and Günal S., and Demir S. (2010) Gold(I) complexes of N-heterocyclic carbene ligands containing benzimidazole: Synthesis and antimicrobial activity. Molecules, 15: 2203-2210.
20. Sadzuka Y., Shoji T., and Takino Y. (1992) Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats. Toxicology Letters, 62: 293-300.
21. Schiller HJ, Reilly PM, and Bulkley GB (1993) Tissue perfusion in critical illnesses. Antioxidant therapy. Critical Care Medicine, 21: 92-102.
22. Sedlak J. and Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry, 25: 192-205.
23. Sheikh-Hamad D., Timmins K., and Jalali Z. (1997) Cisplatin ınduced renal toxicity: possible reversal by N-cetylcysteine treatment. Journal of the American Society of Nephrology, 8: 1640-1644.
24. Shimeda Y., Hirotani Y., Akimoto Y., Shindou K., Ijiri Y., Nishihori T., and Tanaka K. (2005) Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biological and Pharmacological Bulletin, 28: 1635-1638.
25. Simon TM, Kunishima DH, Vilbert GJ, and Lorber A. (1981) Screen trial with a coordinated gold compound auranofin using mouse lymphocytic leukemia P388. Cancer Research, 41: 94-97.
26. Sun Y., Oberley LW, and Li Y. (1988) A simple method for clinical assay of superoxide dismutase. Clinical Chemistry, 34: 497-500.
27. Wang J., He D., Zhang Q., Han Y., Jin S., and Qi F. (2009) Resveratrol protects against Cisplatin induced cardio-toxicity by alleviating oxidative damage. Cancer Biotheraphy and Radiopharmaceuticals, 24: 675-680.
28. Yagi K. (1998) Simple assay for the level of total lipid peroxides in serum or plasma. Methods in Molecular Biology, 108: 101-106.
29. Yüce A., Ateşşahin A., Ceribaşi AO, and Aksakal M. (2007) Ellagic acid prevents cisplatin-induced oxidative stress in liver and heart tissue of rats. Basic Clinical Pharmacology and Toxicology, 101: 345-349.